Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Generex Biotechnology Corp GNBTQ

Healthcare Biotechnology
Generex Biotechnology Corp is a Biotechnology company which is primarily engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. The company operates in the single segment being the Research and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:GNBTQ)

Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th

GlobeNewswire April 9, 2019

Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors

GlobeNewswire April 8, 2019

Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing

GlobeNewswire April 4, 2019

Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million

GlobeNewswire March 29, 2019

Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting

GlobeNewswire March 26, 2019

USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY

GlobeNewswire March 22, 2019

KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019

GlobeNewswire March 20, 2019

KALY Initiates Phase Two Cannabis Extract COPD Treatment Study

GlobeNewswire March 18, 2019

Generex Biotechnology Announces the Appointment of Chief Commercial Officer

GlobeNewswire March 12, 2019
View More News ››

Opinion & Analysis (EXPM:GNBTQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:GNBTQ)

Covid News Feb. 24, 2021

Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program Ii-Key-SARS-CoV-2...
Red~One - February 24, 2021

Generex announces receipt of $2M for its COVID-19 vaccine

Published on: February 10, 2021   Author: Amy Liu        Generex announces...
Red~One - February 17, 2021

GNBT Files Trademark Application for The Complete Vaccine™

Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark...
Red~One - February 9, 2021

Generex Biotech Announces Call-in Details for Feb 5,2021

Update on Ii-Key-SARS-CoV-2 vaccine program China Licensing & Research Agreement advances with $100,000 payment guarantee...
Red~One - February 9, 2021

reading problems

Last Friday the international clearing house that works for my Dutch broker BinckBank, gave Generex a cannabis related indication. This...
nicor123 - May 26, 2020

RE:Huge News

careful on otcbb and pink sheets.
thedave2006 - March 2, 2020
View more Bullboard ››

Fineqia International Inc.

Fineqia International Inc.

Fineqia is a digital asset business that builds and targets investments in early and growth-stage technology companies that ...
View More »